New Biomarkers in Prostate Cancer
Was cited as one of the top 5 oncology review article by Journal Oncology for 2014. By Neal D. Shore, MD, E. David Crawford, MD and Karen Ventii, PhD.


Targeted Immunotherapy for Prostate Cancer with PROSTVAC
Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC targeted immunotherapy for prostate cancer.


Genomic Testing for Newly Diagnosed Low-Risk Prostate Cancer



Approval of enzalutamide pre-chemo a 'game changer'


Welcome to Carolina Urologic Research Center
Carolina Urologic Research Center (CURC), is a separate and independent research arm of Grand Strand Urology, a division of Atlantic Urology Clinics in Myrtle Beach, South Carolina. Under the direction of Dr. Neal Shore, CURC conducts phase I - IV drug, biotechnology and device trials focusing on urological diseases. CURC has been recognized both nationally & internationally as one of the most progressive, well-organized, and respected clinical research sites in the United States.

January 2015
The Addition of Docetaxel to Androgen Deprivation
September 2014
Biomarkers in the Management of Prostate Cancer
facebooktwitter
Studio303